Shared Decision Aid for Post-Total Knee Arthroplasty Opioid Prescribing
Not Applicable
- Conditions
- Knee Arthroplasty, TotalAnalgesiaOpioid Use, Unspecified
- Interventions
- Other: Shared Decision Making
- First Posted Date
- 2020-09-25
- Last Posted Date
- 2022-05-27
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 142
- Registration Number
- NCT04564729
- Locations
- πΊπΈ
University of Chicago Medical Center, Chicago, Illinois, United States
πΊπΈBrigham and Women's Hospital, Boston, Massachusetts, United States
DAW2020 on OSA Endotypic Traits
Phase 1
- Conditions
- Obstructive Sleep Apnea (OSA)
- Interventions
- Drug: Placebo oral capsuleDrug: DAW2020 oral capsule
- First Posted Date
- 2020-09-04
- Last Posted Date
- 2023-07-07
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT04538755
- Locations
- πΊπΈ
Brigham and Women's Hospital, Boston, Massachusetts, United States
Fertility, Hypercoagulability, and Inflammation (FREYA) Registry
Active, not recruiting
- Conditions
- Thrombophilia
- Interventions
- Other: No intervention
- First Posted Date
- 2020-09-03
- Last Posted Date
- 2024-03-05
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 1000
- Registration Number
- NCT04537416
- Locations
- πΊπΈ
Brigham and Women's Hospital, Boston, Massachusetts, United States
Vitamin D for COVID-19 Trial
Phase 3
Completed
- Conditions
- COVID-19
- Interventions
- Dietary Supplement: vitamin DDietary Supplement: Placebo
- First Posted Date
- 2020-09-02
- Last Posted Date
- 2024-07-19
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 2024
- Registration Number
- NCT04536298
- Locations
- πΊπΈ
Brigham and Women's Hospital, Boston, Massachusetts, United States
COVID-19 Registry to Assess Frequency, Risk Factors, Management, and Outcomes of Arterial and Venous Thromboembolic Complications
Recruiting
- Conditions
- Thrombosis EmbolismMyocardial InfarctionCovid19DVTPulmonary EmbolismStroke
- Interventions
- Other: No intervention
- First Posted Date
- 2020-09-01
- Last Posted Date
- 2024-03-05
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 10000
- Registration Number
- NCT04535128
- Locations
- πΊπΈ
Brigham and Women's Hospital, Boston, Massachusetts, United States
Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - TNFi vs Abatacept
Completed
- Conditions
- Rheumatoid Arthritis
- Interventions
- Drug: Tumor Necrosis Factor Inhibitors
- First Posted Date
- 2020-08-28
- Last Posted Date
- 2021-11-23
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 63013
- Registration Number
- NCT04529902
- Locations
- πΊπΈ
Brigham and Women's Hospital, Boston, Massachusetts, United States
Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - Tocilizumab vs Abatacept
- First Posted Date
- 2020-08-28
- Last Posted Date
- 2021-11-16
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 30432
- Registration Number
- NCT04529863
- Locations
- πΊπΈ
Brigham and Women's Hospital, Boston, Massachusetts, United States
Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - Tofacitinib vs Abatacept
- First Posted Date
- 2020-08-28
- Last Posted Date
- 2021-11-16
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 29464
- Registration Number
- NCT04529876
- Locations
- πΊπΈ
Brigham and Women's Hospital, Boston, Massachusetts, United States
Rural Home Hospital: Proof of Concept
Not Applicable
Completed
- Conditions
- InfectionHeart FailureAsthmaGout FlareChronic Kidney DiseasesAtrial Fibrillation RapidChronic Obstructive Pulmonary DiseaseHypertensive UrgencyAnticoagulants; Increased
- Interventions
- Other: Home hospital care
- First Posted Date
- 2020-08-28
- Last Posted Date
- 2025-01-30
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 7
- Registration Number
- NCT04531280
- Locations
- πΊπΈ
University of Utah Health, Salt Lake City, Utah, United States
Aldosterone, the Mineralocorticoid Receptor, and Cardiovascular Disease in Obesity
Phase 4
Recruiting
- Conditions
- HypertensionOverweight and ObesityMetabolic Syndrome
- Interventions
- First Posted Date
- 2020-08-19
- Last Posted Date
- 2023-11-14
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 80
- Registration Number
- NCT04519164
- Locations
- πΊπΈ
Brigham and Women's Hospital, Boston, Massachusetts, United States
Β© Copyright 2025. All Rights Reserved by MedPath